We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSAQ
3251
DELISTED
Direct Selling Acquisition Corp.
DSAQ
-1,129,510
Closed -$11.6M
USCT
3252
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
-425,913
Closed -$4.39M
RMGC
3253
DELISTED
RMG Acquisition Corp. III Class A Ordinary Shares
RMGC
-968,764
Closed -$9.78M
GMDA
3254
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
-313,207
Closed -$404K
KNTE
3255
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
-14,944
Closed -$91.2K
MTBL
3256
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
-22,833
Closed -$36.5K
MVLA
3257
DELISTED
Movella Holdings Inc. Common Stock
MVLA
-1,292,201
Closed -$13M
AWIN
3258
DELISTED
AERWINS Technologies Inc
AWIN
-3,485
Closed -$3.81M
PGTI
3259
DELISTED
PGT, Inc.
PGTI
-48,491
Closed -$871K
TWOA
3260
DELISTED
two
TWOA
-620,975
Closed -$6.25M
LIBY
3261
DELISTED
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
-555,472
Closed -$5.67M
PEPL
3262
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
-748,549
Closed -$7.65M
HCMA
3263
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
-749,996
Closed -$7.69M
KRTX
3264
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-1,207
Closed -$237K
ROSS
3265
DELISTED
Ross Acquisition Corp II
ROSS
-1,665,604
Closed -$16.9M
IRRX
3266
DELISTED
Integrated Rail and Resources Acquisition Corp.
IRRX
-19,000
Closed -$196K
VAQC
3267
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
-2,122,701
Closed -$21.4M
SZZL
3268
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
-71,919
Closed -$735K
ACAH
3269
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
-1,697,110
Closed -$17M
LCAA
3270
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
-1,095,029
Closed -$11.1M
SHAP
3271
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
-827,600
Closed -$8.52M
NRAC
3272
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
-1,149,926
Closed -$11.6M
CPTK
3273
CALL
DELISTED
Crown PropTech Acquisitions
CPTK
-359,593
Closed -$3.64M
CPTK
3274
DELISTED
Crown PropTech Acquisitions
CPTK
-1,260,189
Closed -$12.7M
HHLA
3275
DELISTED
HH&L Acquisition Co.
HHLA
-593,713
Closed -$6M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.